ARRAY BIOPHARMA INC.

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	ARRY
ISIN:

Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

PR Newswire

BOULDER, Colo., Nov. 22, 2016

BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website: www.arraybiopharma.com.

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

Event:	Piper Jaffray Annual Healthcare Conference
Date:	Tuesday, November 29, 2016
Time:	12:35 p.m. Eastern Standard Time

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.

CONTACT:	Tricia Haugeto
	Array BioPharma Inc.
	303-386-1193
	[email protected]

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-piper-jaffray-annual-healthcare-conference-300365720.html

SOURCE Array BioPharma

PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.